Najla Dickson
YOU?
Author Swipe
View article: Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers
Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers Open
These results support the long-term safety and effectiveness of fenfluramine in patients with LGS, with no new safety signals identified, and sustained reductions in seizures and improvement in global functioning observed.
View article: Safety, Tolerability, and Efficacy of Adjunctive Brivaracetam in Japanese and Chinese Patients with Focal-Onset Seizures: Interim Analysis of a Phase 3 Open-Label Extension Trial
Safety, Tolerability, and Efficacy of Adjunctive Brivaracetam in Japanese and Chinese Patients with Focal-Onset Seizures: Interim Analysis of a Phase 3 Open-Label Extension Trial Open
ClinicalTrials.gov NCT03250377. Graphical abstract available for this article.
View article: Treatment with brivaracetam has no apparent long‐term effects on body weight in pediatric patients with epilepsy
Treatment with brivaracetam has no apparent long‐term effects on body weight in pediatric patients with epilepsy Open
Objective The objective of this study is to evaluate possible long‐term effects of treatment with brivaracetam (BRV) on body weight in children with epilepsy. Method Post hoc analysis of data from patients (aged 1 month to <17 years) with …